Skip to main content

Vicente Bebia Conesa

Medical Degree (Universidad de Murcia). Specialist in Gynecology and Obstetrics (Hospital 12 de Octubre, 2018). Gynecologic Oncologist (Vall d'Hebron, endorsed by ESGO).

Institutions of which they are part

Predoctoral researcher
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca
Doctor
Ginecologia Oncològica i Patologia del Tracte Genital Inferior
Children's Hospital and Woman's Hospital

Vicente Bebia Conesa

Institutions of which they are part

Predoctoral researcher
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca
Doctor
Ginecologia Oncològica i Patologia del Tracte Genital Inferior
Children's Hospital and Woman's Hospital

Medical Degree (Universidad de Murcia). Specialist in Gynecology and Obstetrics (Hospital 12 de Octubre, 2018). Gynecologic Oncologist (Vall d'Hebron, endorsed by ESGO).

I was born in Cartagena (Spain) in 1989. I completed my Medical Degree at Universidad de Murcia (Class 2007-2013). Via MIR, I finished the residency program in Obstetrics and Gynecology at Hospital 12 de Octubre (Madrid), where my interest in the surgical treatment of gynecological neoplasms began. After a brief period as a specialist at Hospital 12 de Octubre, I moved to Barcelona to pursue the Fellowship program in Gynecological Oncology at Vall d'Hebron. Currently, and after obtaining the Gynecologic Oncologist diploma endorsed by the European Society of Gynecology Oncology (ESGO), I work at the Gynecology Oncology Unit of Vall d'Hebron.
Along with the daily surgical activity, I do research as a member of the Gynecology Biomedical Research Group at VHIR. My main interests lie in the management and diagnosis of lymph node involvement in gynecological neoplasms (both clinically and surgically), as well as searching for new surgical methods for the treatment of tumors of gynecological origin.

Projects

Desarrollo de una herramienta de diagnóstico precoz de cáncer de endometrio en biopsia líquida cervical

IP: Eva Colas Ortega
Collaborators: Vicente Bebia Conesa, Maria Cristina Centeno Mediavilla, Silvia Franco Camps, Silvia Cabrera Diaz
Funding agency: Instituto de Salud Carlos III
Funding: 93170
Reference: PI17/02155
Duration: 01/01/2018 - 30/06/2022

Related news

From 6th to 7th March, more than 60 European researchers have shared the advances in translational research in endometrial cancer

On January 24, a session was held to explain what these three-dimensional models are and what advantages they have, as well as to review some of their applications in research.

A team from Vall d'Hebron Research Institute (VHIR) and the Autonomous University of Barcelona (UAB) highlights the ERK5 protein as a key factor in the resistance to cancer drugs.

Related professionals

Ines Mercedes Oliveira Souto

Ines Mercedes Oliveira Souto

Main researcher
Infectious Diseases
Read more
Almudena Sanchez Garcia

Almudena Sanchez Garcia

Predoctoral researcher
Biomedical Research in Cancer Stem Cells
Read more
Eduardo Fidel Tizzano

Eduardo Fidel Tizzano

Head of group
Genetics Medicine
Read more
Karla Alejandra  Cameron  Veas

Karla Alejandra Cameron Veas

Research Support. Licensed Technician
Clinical Research Development Area
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.